Acute and subacute stent thrombosis in a patient with clopidogrel resistance: A case report

Korean Circulation Journal

Volumn 39, Issue 10, 2009, Pages 434-438

  Sung, Soo Kim ^a,b   Myung, Ho Jeong ^a,b   Kim, Hyun Kuk ^a,b   Soo, Young Bae ^a   Kyoung, Ho Ryu ^a   Kyung, Hun Cho ^a,b   Min, Chul Kim ^a,b   Keun, Ho Park ^a,b   Doo, Sun Sim ^a,b   Young, Joon Hong ^a,b   Ju, Han Kim ^a,b   Youngkeun, Ahn ^a,b   Jung, Chaee Kang ^a,b  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University   (South Korea)

Author keywords

Clopidogrel; Stents; Thrombosis

Indexed keywords

'TAXUS'; ABCIXIMAB; ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL; PACLITAXEL; UNCLASSIFIED DRUG;

ACUTE DISEASE; ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; DRUG ELUTING STENT; FEMALE; FIBRINOLYTIC THERAPY; HEART CATHETERIZATION; HEART INFARCTION; HEART RIGHT BUNDLE BRANCH BLOCK; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RECURRENT DISEASE; ST SEGMENT ELEVATION; STENT THROMBOSIS; THORAX PAIN; TREATMENT RESPONSE;

EID: 70449556098     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2009.39.10.434     Document Type: Article

References (11)

1. Serruys PW, Degertekin M, Tanabe K, et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (Randomized study with the sirolimus-eluting Velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation 2002; 106: 798-803.
2. Colombo A, Drzewiecki J, Banning A, et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003; 108: 788-794 (Pubitemid 37022118)
3. Zhang F, Ge J, Qian J, et al. Sirolimus-eluting stents in real-world patients with ST-segment elevation acute myocardial infarction. Int Heart J 2007; 48: 303-311 (Pubitemid 47181003)
4. Kim JY, Yoon JH. Aspirin and Clopidogrel resistance in drug eluting stent era. Korean Circ J 2007; 37: 135-147
5. Schuhlen H, Kastrati A, Pache J, Dirschinger J, Schomig A. Incidence of thrombotic occlusion and major adverse cardiac events between two and four weeks after coronary stent placement: analysis of 5,678 patients with a four-week ticlopidine regimen. J Am Coll Cardiol 2001; 37: 2066-2073 (Pubitemid 32547999)
6. De la Torre-Hernandez JM, Alfonso F, Hernandez F, et al. Drug-eluting stent thrombosis: results from the mitlticenter Spanish registry ESTROFA (Estudio ESpanol sobre TROmbosis de stents FArmacoactivos). J Am Coll Cardiol 2008; 51: 986-990 (Pubitemid 351318135)
7. Kuchulakanti, Chu WW, Torguson R, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 2006; 113: 1108-1113 (Pubitemid 43754278)
8. S) Park SH, Hong GR, Seo HS, Tahk SJ. Stent thrombosis after successful drug-eluting stent implantation. Korean Circ J 2005; 35: 163-171
9. Kim SS, Jeong MH, Sim DS, et al. Very late stent thrombosis of drug eluting stent after discontinuation of dual anti-platelet therapy in a patient treated with both drug eluting and bare metal stents. Korean Cir J 2009; 39: 205-208
10. Gum PA, Kottke-Marchant K, Poggio ED, et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 2001; 88: 230-235 (Pubitemid 32721947)
11. Gurbel PA, Blinden KP, Hiatt BL, O'Connor CM. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003; 107: 2908-2913